TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

BPOM takes stomach drugs off market over cancer risk

  • Ardila Syakriah

    The Jakarta Post

Jakarta   /   Tue, October 15 2019   /  12:47 am

The Indonesian Food and Drug Monitoring Agency (BPOM) has suspended sales of drugs containing ranitidine, commonly used to treat stomach problems, following reports from the United States and Europe that the medication may be contaminated with a carcinogenic substance.The BPOM approved ranitidine medicines, used to decrease stomach acid production, for sale in the country in 1989.However, recent findings by the US Food and Drug Administration and the European Medicine Agency (EMA) that ranitidine product samples contained a small amount of N-Nitrosodimethylamine (NDMA) had prompted the agency to conduct a risk assessment of all products containing ranitidine, the BPOM said in a statement on Oct. 4.The agency cited a global study that determined the acceptable daily intake of NDMA at 96 nanograms. An intake higher than that would be carcinogenic under long-term consumption, meaning it wou...